C2I GENOMICS
C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations. The cancer intelligence company is developing a platform that can perform whole-genome sequencing using only 2 milliliters of blood. Its ultra-sensitive liquid biopsy assay allows physicians to monitor patient treatment response and detect treatment failure or disease recurrence months and potentially years earlier than current monitoring methods. C2i’s cancer diagnostics service uses ... artificial intelligence pattern recognition and the whole-genome analysis to spot trace amounts of cancer much quicker, in about a week, to inform better treatment decisions and ultimately save lives. The company aims to help patients avoid unnecessary overtreatment with toxic chemotherapy or radiation, as well as to prevent them from going without treatment while cancer quietly grows and metastasizes. In 2019, Boris Oklander, Asaf Zviran, and Ezra Sofer established the company in New York, New York.
C2I GENOMICS
Industry:
Genetics Health Care Health Diagnostics Therapeutics
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.c2i-genomics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
112 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Denali Therapeutics
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
iGlobe Partners
iGlobe Partners investment in Series B - C2i Genomics
Duquesne Family Office
Duquesne Family Office investment in Series B - C2i Genomics
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Series B - C2i Genomics
LionBird
LionBird investment in Series B - C2i Genomics
Section 32
Section 32 investment in Series B - C2i Genomics
Driehaus Capital Management
Driehaus Capital Management investment in Series B - C2i Genomics
Casdin Capital
Casdin Capital investment in Series B - C2i Genomics
NFX
NFX investment in Series B - C2i Genomics
The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research investment in Series B - C2i Genomics
Silver Lake
Silver Lake investment in Series B - C2i Genomics
Official Site Inspections
http://www.c2i-genomics.com Semrush global rank: 3.75 M Semrush visits lastest month: 3.6 K
- Host name: server-3-167-112-82.iad55.r.cloudfront.net
- IP address: 3.167.112.82
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "C2i Genomics"
C2i Genomics - LinkedIn
C2i Genomics Wellness and Fitness Services New York, NY 6,162 followers C2i Genomics is …See details»
C2i Genomics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for C2i …See details»
C2i Genomics - Contacts, Employees, Board Members
Organization. C2i Genomics . Connect to CRM . Save . Summary. Financials. People. …See details»
C2I Genomics - Overview, News & Similar companies - ZoomInfo
Who is C2I Genomics. Founded in 2019, C2i Genomics has created the world's leading cancer …See details»
C2i Genomics - PitchBook
C2i Genomics was founded in 2019. Where is C2i Genomics headquartered? C2i Genomics is headquartered in New York, NY. What is the size of C2i Genomics? C2i Genomics has 64 total employees. What industry is C2i Genomics in? C2i …See details»
Cancer care startup C2i Genomics acquired by Veracyte …
Jan 8, 2024 Israeli startup C2i Genomics is being acquired by cancer diagnostics company Veracyte for up to $95 million. Under the terms of the agreement, Veracyte will pay $70 million in Veracyte shares at closing, and up …See details»
Veracyte acquires C2i Genomics - 2024-01-08 - Crunchbase
Jan 8, 2024 Veracyte acquires C2i Genomics on 2024-01-08 for $70000000. Search …See details»
C2i Genomics lands $100M to scale up software that detects tiny …
Apr 16, 2021 At barely two years old, C2i Genomics is already going through a major growth …See details»
Why C2i is the World's First Platform for Cancer …
NFX was an early stage investor in C2i due to their long-term vision and world-changing technology. Listen to NFX Partner Omri Amirav-Drory talk with Asaf Zviran, Co-founder & CEO of C2i Genomics, about the future of their …See details»
C2i Genomics Raises $12 Million in Series A Funding
Jun 9, 2020 C2i Genomics’ innovative solution is based on research performed at the New York Genome Center (NYGC) and Weill Cornell Medicine (WCM) by Dr. Zviran, along with Dr. Dan Landau, core faculty ...See details»
ASCO: Inside C2i Genomics’ precision oncology ‘one-stop shop’
Jun 3, 2023 Boris Oklander, Ph.D., another C2i co-founder and its chief technology officer, …See details»
C2i Genomics - Updates, News, Events, Signals & Triggers
C2i Genomics may be growing as evidenced by its acquisition by Veracyte for $70 million, …See details»
How C2i Genomics builds on AWS to transform cancer care
C2i Genomics, founded in 2019, is one such startup: C2i Genomics is building a whole genome …See details»
C2i Genomics Raises $100 Million To Commercialize the Detection …
Apr 15, 2021 About C2i Genomics Founded in 2019, C2i Genomics has created the world’s …See details»
C2i Genomics Appoints Chief Medical Officer to Scale Its AI
Aug 12, 2021 C2i Genomics, a cancer intelligence company, today announced the …See details»
C2i Genomics - Funding, Financials, Valuation & Investors
C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and …See details»
A sensitive strategy for tumour surveillance - Nature
Jun 24, 2021 C2i Genomics is a spin-off from the New York Genome Center, New York City, …See details»
C2i, a genomics SaaS product to detect traces of cancer
Apr 15, 2021 C2i Genomics has developed software that’s 100x more sensitive in detecting …See details»
Series B - C2i Genomics - 2021-04-15 - Crunchbase
Apr 15, 2021 C2i Genomics raised $100000000 on 2021-04-15 in Series B. Casdin Capital …See details»